DE2508312C2 - - Google Patents

Info

Publication number
DE2508312C2
DE2508312C2 DE2508312A DE2508312A DE2508312C2 DE 2508312 C2 DE2508312 C2 DE 2508312C2 DE 2508312 A DE2508312 A DE 2508312A DE 2508312 A DE2508312 A DE 2508312A DE 2508312 C2 DE2508312 C2 DE 2508312C2
Authority
DE
Germany
Prior art keywords
mmol
acid
sugar
silylated
catalyst
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2508312A
Other languages
German (de)
English (en)
Other versions
DE2508312A1 (de
Inventor
Helmut Dr. 1000 Berlin De Vorbrueggen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Priority to DE19752508312 priority Critical patent/DE2508312A1/de
Priority to NL7601625A priority patent/NL7601625A/xx
Priority to LU74411A priority patent/LU74411A1/xx
Priority to CA246,368A priority patent/CA1065315A/en
Priority to GB767006A priority patent/GB1542442A/en
Priority to SE7602109A priority patent/SE7602109L/xx
Priority to US05/660,675 priority patent/US4082911A/en
Priority to DK77176A priority patent/DK138900C/da
Priority to BE164585A priority patent/BE838879A/xx
Priority to JP51019810A priority patent/JPS51125382A/ja
Priority to CH227476A priority patent/CH626093A5/de
Priority to FR7605030A priority patent/FR2301536A1/fr
Publication of DE2508312A1 publication Critical patent/DE2508312A1/de
Application granted granted Critical
Publication of DE2508312C2 publication Critical patent/DE2508312C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
DE19752508312 1975-02-24 1975-02-24 Neues verfahren zur herstellung von nucleosiden Granted DE2508312A1 (de)

Priority Applications (12)

Application Number Priority Date Filing Date Title
DE19752508312 DE2508312A1 (de) 1975-02-24 1975-02-24 Neues verfahren zur herstellung von nucleosiden
NL7601625A NL7601625A (nl) 1975-02-24 1976-02-18 Werkwijze voor het bereiden van nucleosiden.
CA246,368A CA1065315A (en) 1975-02-24 1976-02-23 Process for producing nucleosides
GB767006A GB1542442A (en) 1975-02-24 1976-02-23 Process for the manufacture of nucleosides
SE7602109A SE7602109L (sv) 1975-02-24 1976-02-23 Nytt forfaringssett for framstellning av nukleosider
US05/660,675 US4082911A (en) 1975-02-24 1976-02-23 Process for the preparation of nucleosides
LU74411A LU74411A1 (US07608600-20091027-C00048.png) 1975-02-24 1976-02-23
BE164585A BE838879A (fr) 1975-02-24 1976-02-24 Nouveau procede de preparation de nucleosides
DK77176A DK138900C (da) 1975-02-24 1976-02-24 Fremgangsmaade til fremstilling af nucleosider
JP51019810A JPS51125382A (en) 1975-02-24 1976-02-24 Production of nucleotide
CH227476A CH626093A5 (US07608600-20091027-C00048.png) 1975-02-24 1976-02-24
FR7605030A FR2301536A1 (fr) 1975-02-24 1976-02-24 Procede de preparation de nucleosides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752508312 DE2508312A1 (de) 1975-02-24 1975-02-24 Neues verfahren zur herstellung von nucleosiden

Publications (2)

Publication Number Publication Date
DE2508312A1 DE2508312A1 (de) 1976-09-02
DE2508312C2 true DE2508312C2 (US07608600-20091027-C00048.png) 1987-10-29

Family

ID=5939872

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752508312 Granted DE2508312A1 (de) 1975-02-24 1975-02-24 Neues verfahren zur herstellung von nucleosiden

Country Status (12)

Country Link
US (1) US4082911A (US07608600-20091027-C00048.png)
JP (1) JPS51125382A (US07608600-20091027-C00048.png)
BE (1) BE838879A (US07608600-20091027-C00048.png)
CA (1) CA1065315A (US07608600-20091027-C00048.png)
CH (1) CH626093A5 (US07608600-20091027-C00048.png)
DE (1) DE2508312A1 (US07608600-20091027-C00048.png)
DK (1) DK138900C (US07608600-20091027-C00048.png)
FR (1) FR2301536A1 (US07608600-20091027-C00048.png)
GB (1) GB1542442A (US07608600-20091027-C00048.png)
LU (1) LU74411A1 (US07608600-20091027-C00048.png)
NL (1) NL7601625A (US07608600-20091027-C00048.png)
SE (1) SE7602109L (US07608600-20091027-C00048.png)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608600B2 (en) 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
US7625875B2 (en) 2002-06-28 2009-12-01 Idenix Pharmaceuticals, Inc. 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
US7781576B2 (en) 2005-12-23 2010-08-24 Idenix Pharmaceuticals, Inc. Process for preparing a synthetic intermediate for preparation of branched nucleosides
US7824851B2 (en) 2002-11-15 2010-11-02 Idenix Pharmaceuticals, Inc. 2′-branched nucleosides and Flaviviridae mutation
US8299038B2 (en) 2000-05-23 2012-10-30 Idenix Pharmaceuticals, Inc. Methods and compositions for treating hepatitis C virus
US8343937B2 (en) 2000-05-26 2013-01-01 Idenix Pharmaceuticals, Inc. Methods and compositions for treating flaviviruses and pestiviruses

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53108986A (en) * 1977-03-02 1978-09-22 Mitsui Toatsu Chem Inc Preparation of nucleosides and nucleotides
DE2721466A1 (de) * 1977-05-12 1978-11-16 Robugen Gmbh Verfahren zur herstellung von 2'-desoxyribofuranosylnucleosiden
US4195176A (en) * 1977-10-11 1980-03-25 Warner-Lambert Company Imidazole compounds, methods for their production and conversion of said compounds into (R)-3-(2-deoxy-β-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazol[4,5-d][1,3]diazepin-8-ol
DE2757365A1 (de) * 1977-12-20 1979-06-21 Schering Ag Neues verfahren zur herstellung von nucleosiden
JPH029511U (US07608600-20091027-C00048.png) * 1988-06-21 1990-01-22
CA2091732C (en) * 1992-07-08 1998-07-21 Anica Markovac A process for the preparation of 2-fluoro-9-(2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl) adenine
JPH07276137A (ja) * 1994-03-31 1995-10-24 Osaka Diamond Ind Co Ltd 切削・研削用工具
DE19513330A1 (de) * 1995-04-03 1996-10-10 Schering Ag Neues Verfahren zur Herstellung von Nucleosiden
US6887855B2 (en) * 2003-03-17 2005-05-03 Pharmion Corporation Forms of 5-azacytidine
US7038038B2 (en) * 2003-03-17 2006-05-02 Pharmion Corporation Synthesis of 5-azacytidine
US6943249B2 (en) * 2003-03-17 2005-09-13 Ash Stevens, Inc. Methods for isolating crystalline Form I of 5-azacytidine
WO2004096149A2 (en) 2003-04-28 2004-11-11 Idenix (Cayman) Limited Industrially scalable nucleoside synthesis
KR20060035652A (ko) 2003-06-30 2006-04-26 이데닉스 (케이만) 리미티드 β-Ｌ-2-데옥시 뉴클레오시드의 합성
AT502635A1 (de) * 2005-11-09 2007-05-15 Saischek Und Partner Meg Neue 1,3-dithioverbindungen, verfahren zu deren herstellung und ihre verwendung
EP2048151A1 (en) * 2007-10-10 2009-04-15 Cilag AG Method for producing nucleosides by direct glycosylation of the nucleoside base
EP2050757A1 (en) * 2007-10-10 2009-04-22 Cilag AG Method of producing 2' -deoxy-5-azacytidine (Decitabine)
ES2774226T3 (es) 2008-05-15 2020-07-17 Celgene Corp Formulaciones orales de análogos de citidina y métodos de uso de los mismos
EP2321302B1 (en) * 2008-08-01 2014-10-29 Dr. Reddy's Laboratories Ltd. Azacitidine process and polymorphs
EP2520581A1 (en) * 2008-08-06 2012-11-07 Sicor, Inc. Method for the determination the purity of 5-Azacytidine
CN102216315B (zh) * 2008-08-08 2016-06-29 台湾神隆股份有限公司 制备5-氮杂胞嘧啶核苷和其衍生物的方法
EP2424845A4 (en) * 2009-04-27 2014-03-05 Reddys Lab Ltd Dr PREPARATION OF DECITABIN
RU2013148580A (ru) 2011-03-31 2015-05-10 Селджин Интернешнл Сарл Синтез 5-азацитидина
CN108239128B (zh) * 2016-12-23 2019-03-29 江苏奥赛康药业股份有限公司 β-核苷类化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3354160A (en) * 1965-07-22 1967-11-21 Hoffmann La Roche Tri-lower alkyl-silyl-5-fluoropyrimidines
US3352849A (en) * 1965-10-24 1967-11-14 Merck & Co Inc 6-aza-2'-deoxyuridines
SU452961A3 (ru) * 1969-04-11 1974-12-05 Шеринг Аг. (Фирма) Способ получени пиримидиннуклеозидов
DE2122991C2 (de) * 1971-05-04 1982-06-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von Cytosin- und 6-Azacytosinnucleosiden

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8299038B2 (en) 2000-05-23 2012-10-30 Idenix Pharmaceuticals, Inc. Methods and compositions for treating hepatitis C virus
US8343937B2 (en) 2000-05-26 2013-01-01 Idenix Pharmaceuticals, Inc. Methods and compositions for treating flaviviruses and pestiviruses
US7608600B2 (en) 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
US7625875B2 (en) 2002-06-28 2009-12-01 Idenix Pharmaceuticals, Inc. 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
US7635689B2 (en) 2002-06-28 2009-12-22 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
US7662798B2 (en) 2002-06-28 2010-02-16 Idenix Pharmaceuticals, Inc. 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
US7824851B2 (en) 2002-11-15 2010-11-02 Idenix Pharmaceuticals, Inc. 2′-branched nucleosides and Flaviviridae mutation
US8674085B2 (en) 2002-11-15 2014-03-18 Idenix Pharmaceuticals, Inc. 2′-branched nucleosides and Flaviviridae mutation
US7781576B2 (en) 2005-12-23 2010-08-24 Idenix Pharmaceuticals, Inc. Process for preparing a synthetic intermediate for preparation of branched nucleosides

Also Published As

Publication number Publication date
BE838879A (fr) 1976-08-24
GB1542442A (en) 1979-03-21
CH626093A5 (US07608600-20091027-C00048.png) 1981-10-30
DK138900B (da) 1978-11-13
SE7602109L (sv) 1976-08-25
US4082911A (en) 1978-04-04
DK138900C (da) 1979-04-30
JPS6139318B2 (US07608600-20091027-C00048.png) 1986-09-03
CA1065315A (en) 1979-10-30
JPS51125382A (en) 1976-11-01
NL7601625A (nl) 1976-08-26
DK77176A (da) 1976-08-25
FR2301536A1 (fr) 1976-09-17
LU74411A1 (US07608600-20091027-C00048.png) 1976-08-13
FR2301536B1 (US07608600-20091027-C00048.png) 1979-07-27
DE2508312A1 (de) 1976-09-02

Similar Documents

Publication Publication Date Title
DE2508312C2 (US07608600-20091027-C00048.png)
EP0003229B1 (de) Neues Verfahren zur Herstellung von Nucleosiden
DE69816992T2 (de) Benzimidazolderivate
DE2012888C3 (de) Verfahren zur Herstellung von 5-Azapyrimidinnucleosiden
EP0484333B1 (de) Nucleosid-derivate und deren verwendung als arzneimittel
EP0257378B1 (de) Pyrimidinderivate, ihre Herstellung und Medikamente, die diese Derivate enthalten
DE2056327C2 (de) 2,6-Diamino-9-(β-D-arabinofuranosyl)-purin, dessen N-6-Niedrigalkylderivate, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen, welche diese Verbindungen enthalten
DE2555479A1 (de) Verfahren zur herstellung von 3', 4'-alpha-epoxyneamin und verwandten aminoglykosidischen antibiotika sowie die so hergestellten verbindungen
DE60204859T2 (de) Verfahren zur Herstellung von 2'-Halo-beta-L-arabino-furanosylnucleosiden
EP0763047B1 (de) Neues verfahren zur herstellung von nucleosiden
DD255351A5 (de) Verfahren zur herstellung von carbocyclischen purinnucleosiden
DE2552293A1 (de) Antileukaemische verbindungen, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE3508356C2 (US07608600-20091027-C00048.png)
Urbas et al. Synthesis of Purine and Pyrimidine Nucleosides of Thiopentoses1
Chu et al. Nucleosides. 107. Synthesis of 5-(. beta.-D-arabinofuranosyl) isocytosine and related C-nucleosides
DE2402804A1 (de) Adenosinderivate
DE2226295A1 (de) Salpetersaeureester von purinnucleosiden und verfahren zur herstellung derselben
DE1943428C3 (de) Verfahren zur Herstellung von Pyrimidin- und 6-Azauracilnueleosiden
DE1240863B (de) Verfahren zur Oxydation von Alkoholen zu den entsprechenden Aldehyden oder Ketonen
WO1993011144A1 (de) Neues verfahren zur herstellung von 2-fluorpurin-derivaten
DE2053672A1 (de) Alkyl 7 O alkyl I thio alpha Iincosaminid derivate und Verfahren zu deren Herstellung
DE2208542A1 (de) Synthetische Nucleoside vom Polyoxintyp und Verfahren zur Herstellung von Hexofuranosyluronamidnucleosiden
DE4430401A1 (de) D-Xylofuranose-Derivate, Verfahren zu deren Herstellung, deren Verwendung und neue Zwischenverbindungen für das Verfahren
CH518311A (de) Verfahren zur Herstellung von in 6-Stellung halogensubstituierten Purinribonucleosid-3':5'-cyclophosphaten und deren Verwendung zur Herstellung der entsprechenden Äther
AT267074B (de) Verfahren zur Herstellung von 5-Fluoro-uracil- und 5-Fluoro-cytosin-Nucleosiden

Legal Events

Date Code Title Description
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee